search
Back to results

Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery

Primary Purpose

Inflammation, Cardiac Surgical Procedures

Status
Completed
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
a combination of MCT, LCT , and Fish Oil
Sponsored by
University of Alberta
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inflammation focused on measuring Intensive Care,Neonatal, Parenteral nutrition, Fat emulsions,Intravenous

Eligibility Criteria

undefined - 3 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 36 weeks gestation 3 months corrected age appropriate for gestational age (AGA) admitted for surgical correction of congenital heart defects (single ventricle, tetralogy of Fallot, truncus and complex biventricular repairs) enteral nutrition at 30 kcal/kilogram/day Exclusion Criteria: 5 minute Apgar score of 4 major congenital defect other than heart defect presence of significant neonatal morbidity (intraventricular hemorrhage (IVH) grade 3 or greater, necrotizing enterocolitis (NEC) and surgical abdomen) any metabolic disorder any endocrine disorder medications which alter eicosanoid metabolism including indomethacin, acetylsalicylate (with exception of steroids which will be analyzed independently)

Sites / Locations

  • Stollery Children's Hospital

Outcomes

Primary Outcome Measures

To determine whether incidence of sepsis and degree of inflammatory response is altered

Secondary Outcome Measures

To characterize serum arachidonic acid and eicosapentaenoic acid levels, leukotriene B 4/leukotriene B 5 levels and incidence of nosocomial infection
To characterize incidental findings as a result of attaining complete fatty acid and cytokine profiles

Full Information

First Posted
June 13, 2006
Last Updated
November 26, 2007
Sponsor
University of Alberta
Collaborators
Stollery Children's Hospital Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00336908
Brief Title
Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery
Official Title
Inflammatory Responses of Intravenous Fish Oil, Soybean Oil and Medium Chain Triglyceride Fat Emulsions in Young Children Before and After Open Heart Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
November 2007
Overall Recruitment Status
Completed
Study Start Date
November 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
November 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Alberta
Collaborators
Stollery Children's Hospital Foundation

4. Oversight

5. Study Description

Brief Summary
This study is a blinded, randomized, controlled prospective trial comparing immune response (sepsis, inflammatory response, pulmonary vasoconstriction) in 2 groups of infants less than 3-month old receiving pre and post cardiopulmonary bypass surgery. The infants will receive 1 out of the 2 following intravenous lipid preparations: Soybean Oil (n-6), or a combination of Medium Chain Triglyceride i.e. coconut oil, Long Chain Triglyceride i.e. Soybean Oil, and Fish Oil (MCT:LCT:FO). There will be 16 subjects in each group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammation, Cardiac Surgical Procedures
Keywords
Intensive Care,Neonatal, Parenteral nutrition, Fat emulsions,Intravenous

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
32 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
a combination of MCT, LCT , and Fish Oil
Primary Outcome Measure Information:
Title
To determine whether incidence of sepsis and degree of inflammatory response is altered
Secondary Outcome Measure Information:
Title
To characterize serum arachidonic acid and eicosapentaenoic acid levels, leukotriene B 4/leukotriene B 5 levels and incidence of nosocomial infection
Title
To characterize incidental findings as a result of attaining complete fatty acid and cytokine profiles

10. Eligibility

Sex
All
Maximum Age & Unit of Time
3 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 36 weeks gestation 3 months corrected age appropriate for gestational age (AGA) admitted for surgical correction of congenital heart defects (single ventricle, tetralogy of Fallot, truncus and complex biventricular repairs) enteral nutrition at 30 kcal/kilogram/day Exclusion Criteria: 5 minute Apgar score of 4 major congenital defect other than heart defect presence of significant neonatal morbidity (intraventricular hemorrhage (IVH) grade 3 or greater, necrotizing enterocolitis (NEC) and surgical abdomen) any metabolic disorder any endocrine disorder medications which alter eicosanoid metabolism including indomethacin, acetylsalicylate (with exception of steroids which will be analyzed independently)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John E Van Aerde, MD, PhD
Organizational Affiliation
University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stollery Children's Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2B7
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
22136963
Citation
Larsen BM, Goonewardene LA, Joffe AR, Van Aerde JE, Field CJ, Olstad DL, Clandinin MT. Pre-treatment with an intravenous lipid emulsion containing fish oil (eicosapentaenoic and docosahexaenoic acid) decreases inflammatory markers after open-heart surgery in infants: a randomized, controlled trial. Clin Nutr. 2012 Jun;31(3):322-9. doi: 10.1016/j.clnu.2011.11.006. Epub 2011 Dec 3.
Results Reference
derived

Learn more about this trial

Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery

We'll reach out to this number within 24 hrs